Method for the diagnosis of chronic stress and related disorders
View Patent ↗Methods for diagnosing chronic stress in patients by first determining the level of one or more analytes in a patient sample and establishing the significance of the one or more analyte levels.
1. A method of diagnosis of chronic stress in a patient, which comprises:
(a) determining the level of each of analytes vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP1) and epidermal growth factor (EGF) in a sample taken from the patient; and
(b) establishing the significance of each analyte level by comparing each analyte level to the same analyte levels measured in a healthy control sample, and diagnosing chronic stress in the patient when each analyte level is elevated relative to the analyte levels measured in the healthy control sample.
2. A method according to claim 1 , wherein the sample is a blood sample.
3. A method of diagnosis of chronic stress in a patient, which comprises:
(a) determining the level of each of analytes vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP1) and epidermal growth factor (EGF) in a sample taken from the patient; and
(b) establishing the significance of each analyte level by comparing each analyte level with those of a control sample, wherein the control sample is from a person who is not suffering from a major depressive disorder and diagnosing chronic stress in the patient when each analyte level is elevated relative to the analyte levels in the control sample.
4. A method according to claim 1 or 2 wherein step (a) additional comprises determining the level of interluken-8 (IL-8).
5. A method according to claim 4 wherein step (a) additional comprises determining the level of thyroid stimulating hormone (TSH).
6. A method according to claim 1 or 2 wherein step (a) additional comprises determining the level of thyroid stimulating hormone (TSH).
7. A method according to claim 3 , wherein the patient sample is a blood sample.